157 related articles for article (PubMed ID: 15927828)
1. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
[TBL] [Abstract][Full Text] [Related]
2. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
3. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
Sener SF; Winchester DJ; Winchester DP; Du H; Barrera E; Bilimoria M; Krantz S; Rabbitt S
Am J Surg; 2009 Mar; 197(3):403-7. PubMed ID: 19245923
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
5. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
6. Weight gain prior to diagnosis and survival from breast cancer.
Cleveland RJ; Eng SM; Abrahamson PE; Britton JA; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1803-11. PubMed ID: 17855698
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.
Huang B; Carloss H; Wyatt SW; Riley E
Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
[TBL] [Abstract][Full Text] [Related]
9. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy and breast cancer: what factors modify the association?
Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
[TBL] [Abstract][Full Text] [Related]
11. Type and duration of exogenous hormone use affects breast cancer histology.
Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
[TBL] [Abstract][Full Text] [Related]
12. Improved breast cancer survival among hormone replacement therapy users is durable after 5 years of additional follow-up.
Christante D; Pommier S; Garreau J; Muller P; LaFleur B; Pommier R
Am J Surg; 2008 Oct; 196(4):505-11. PubMed ID: 18809052
[TBL] [Abstract][Full Text] [Related]
13. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.
Jernström H; Frenander J; Fernö M; Olsson H
Br J Cancer; 1999 Jul; 80(9):1453-8. PubMed ID: 10424750
[TBL] [Abstract][Full Text] [Related]
15. NSAID use and survival after breast cancer diagnosis in post-menopausal women.
Blair CK; Sweeney C; Anderson KE; Folsom AR
Breast Cancer Res Treat; 2007 Jan; 101(2):191-7. PubMed ID: 16823508
[TBL] [Abstract][Full Text] [Related]
16. [HRT in post menopausal women and breast cancer at the Institut Curie].
Czernichow C; This P; Asselain B; Falcou MC; Savignoni A; Salmon RJ; ; Sigal-Zafrani B
Bull Cancer; 2007 May; 94(5):469-75. PubMed ID: 17535785
[TBL] [Abstract][Full Text] [Related]
17. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme.
Gertig DM; Erbas B; Fletcher A; Amos A; Kavanagh AM
Breast Cancer Res Treat; 2003 Aug; 80(3):267-73. PubMed ID: 14503799
[TBL] [Abstract][Full Text] [Related]
18. Social networks, social support, and survival after breast cancer diagnosis.
Kroenke CH; Kubzansky LD; Schernhammer ES; Holmes MD; Kawachi I
J Clin Oncol; 2006 Mar; 24(7):1105-11. PubMed ID: 16505430
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and survival after colorectal cancer diagnosis.
Chan JA; Meyerhardt JA; Chan AT; Giovannucci EL; Colditz GA; Fuchs CS
J Clin Oncol; 2006 Dec; 24(36):5680-6. PubMed ID: 17179103
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]